Artios Pharma Ltd
Clinical trials sponsored by Artios Pharma Ltd, explained in plain language.
-
New pill targets cancer's repair system in advanced tumors
Disease control Recruiting nowThis study tests a new oral drug called ART6043, which blocks a DNA repair protein in cancer cells. It is given alone or with olaparib to adults with advanced or metastatic solid tumors that have not responded to other treatments. The goal is to see if it is safe and can shrink o…
Phase: PHASE1, PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated May 16, 2026 23:34 UTC
-
New drug ART0380 shows promise in early trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called ART0380 in people with advanced or metastatic solid tumors (cancers that have spread). The goal is to find a safe dose and see if it works alone or with other chemotherapy drugs like gemcitabine or irinotecan. About 442 participants wi…
Phase: PHASE1, PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC